---
trial_id: 320
discovery_date: 2022-04-02 17:30:16.043517
date: 2022-04-02 17:30:16.043517
title: "A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with Systemic Sclerosis associated Interstitial Lu..."
summary: |
  <p>EudraCT Number: 2015-000392-28<br />Sponsor Protocol Number: 1199.214<br />Sponsor Name: Boehringer Ingelheim bv<br />Start Date: 2015-11-02<br />Medical condition: Patients with Systemic Sclerosis and associated Interstitial Lung Disease<br />Disease: <br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10012977<br />Term: Diffuse systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10036814<br />Term: Progressive systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders<br />Classification Code: 10042954<br />Term: Systemic sclerosis pulmonary<br />Level: PT<br />Version: 19.1<br />SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders<br />Classification Code: 10025109<br />Term: Lung involvement in systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10042953<br />Term: Systemic sclerosis<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/NL">NL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/PT">PT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/DK">DK</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/GR">GR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/FR">FR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/IE">IE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/NO">NO</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/AT">AT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/HU">HU</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/IT">IT</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-000392-28'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2015-000392-28<br />Sponsor Protocol Number: 1199.214<br />Sponsor Name: Boehringer Ingelheim bv<br />Start Date: 2015-11-02<br />Medical condition: Patients with Systemic Sclerosis and associated Interstitial Lung Disease<br />Disease: <br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10012977<br />Term: Diffuse systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10036814<br />Term: Progressive systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders<br />Classification Code: 10042954<br />Term: Systemic sclerosis pulmonary<br />Level: PT<br />Version: 19.1<br />SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders<br />Classification Code: 10025109<br />Term: Lung involvement in systemic sclerosis<br />Level: LLT<br />Version: 19.1<br />SOC Term: 100000004859<br />Classification Code: 10042953<br />Term: Systemic sclerosis<br />Level: LLT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/NL">NL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/GB">GB</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/PT">PT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/DK">DK</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/GR">GR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/FR">FR</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/IE">IE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/NO">NO</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/SE">SE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/AT">AT</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/HU">HU</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-000392-28/IT">IT</a> (Completed)</p>